MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1161/jaha.126.050214

Медицинская библиотека · Journal of the American Heart Association · 2026

Association of Summed Rest Score on Technetium-99m Sestamibi With Exercise Capacity and Incident Adverse Outcomes in Hospitalized Patients With Nonischemic Cardiomyopathy: A Retrospective Analysis.

Mima Hibiki, Sera Fusako, Ohtani Tomohito, Akazawa Yasuhiro, Konishi Shozo, Oka Takafumi, Sakata Yasushi

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

In nonischemic cardiomyopathy, the clinical relevance of decreased resting myocardial technetium-99m sestamibi (99mTc-MIBI) uptake regarding exercise capacity and clinical outcomes remains incompletely understood. We investigated whether decreased 99mTc-MIBI uptake is associated with impaired exercise capacity and adverse clinical outcomes in nonischemic cardiomyopathy.

METHODS

We retrospectively analyzed 182 patients (mean age 51.4±14.0 years; 27% female) with nonischemic cardiomyopathy and left ventricular ejection fraction <50% who underwent 99mTc-MIBI scintigraphy and cardiopulmonary exercise testing from 2016 to 2023. Myocardial uptake of 99mTc-MIBI was evaluated using the summed rest score (SRS). Exercise capacity was assessed by percentage of predicted peak oxygen consumption (PPVO2), with ≤60% defining impairment.

RESULTS

Seventy-four patients (41%) had PPVO2 ≤60% and higher SRS (median: 12 versus 8; P < 0.001). Higher SRS remained significantly associated with PPVO2 ≤60% after adjustment for relevant clinical covariates, including brain natriuretic peptide level, left ventricular ejection fraction, and heart failure duration. Over a median follow-up of 807 days, 23 patients (13%) experienced the composite outcome of all-cause death, ventricular assist device implantation, or heart transplantation. Higher SRS was associated with composite outcomes after adjusting for PPVO2 ≤60%. Among the 4 groups stratified by median SRS of 9 and PPVO2 of 60%, patients with high SRS and low PPVO2 had the highest incidence of adverse events.

CONCLUSIONS

Decreased myocardial 99mTc-MIBI uptake was associated with impaired exercise capacity and adverse outcomes in patients with nonischemic cardiomyopathy. Our findings suggest that myocardial injury assessment using 99mTc-MIBI scintigraphy may provide prognostic information complementary to exercise capacity.

Для цитирования: Mima Hibiki, Sera Fusako, Ohtani Tomohito, Akazawa Yasuhiro, Konishi Shozo, Oka Takafumi, Sakata Yasushi. Association of Summed Rest Score on Technetium-99m Sestamibi With Exercise Capacity and Incident Adverse Outcomes in Hospitalized Patients With Nonischemic Cardiomyopathy: A Retrospective Analysis.. Journal of the American Heart Association. 2026. DOI: 10.1161/jaha.126.050214.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.